Equity Capital Markets

Company · CIK 1799788

Greenwich LifeSciences, Inc.

CIK1799788 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressTX
ListedGLSI (Nasdaq)
First annual or quarterly report2020-11-16

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-282533
ShelfEffective
 2024-10-072024-10-172
333-263855
ShelfEffective
 2022-03-252022-07-123
333-251366
Registered companyFinal prospectus
 2020-12-152020-12-183
333-238829
IPOFinal prospectus
 2020-05-292020-09-288

Filings

18
FiledFilingRegistrationAccession
2024-10-17EFFECTDeclared effective 333-2825339999999995-24-003208
2024-10-07S-3Shelf registered 333-2825330001493152-24-040312
2022-07-12424B5Shelf takedown 333-2638550001493152-22-019041
2022-04-06EFFECTDeclared effective 333-2638559999999995-22-000849
2022-03-25S-3Shelf registered 333-2638550001493152-22-007755
2020-12-18424B4Final prospectus 333-2513660001493152-20-023937
2020-12-17EFFECTDeclared effective 333-2513669999999995-20-003575
2020-12-15S-1Registration filed 333-2513660001493152-20-023661
2020-12-07DRSDraft made public 377-038570001493152-20-023021
2020-09-28424B4Final prospectus 333-2388290001213900-20-028598
2020-09-28424B4Final prospectus 333-2388290001213900-20-028595
2020-09-24EFFECTDeclared effective 333-2388299999999995-20-002560
2020-09-10S-1/AAmendment 333-2388290001213900-20-026086
2020-09-09S-1/AAmendment 333-2388290001213900-20-025712
2020-06-26S-1/AAmendment 333-2388290001213900-20-015904
2020-06-23S-1/AAmendment 333-2388290001213900-20-015502
2020-05-29S-1Registration filed 333-2388290001213900-20-013732
2020-01-28DRSDraft made public 377-030160001213900-20-001960

All filings of this company · CSV